Ford Motor is about to report earnings. Here’s what to expect

Ford Motor is about to report earnings. Here’s what to expect


The Ford display at the New York International Auto Show on March 28, 2024. 

Danielle DeVries | CNBC

DETROIT — Ford Motor is set to report second-quarter earnings after the markets close Wednesday.

The Detroit automaker’s results are expected to be relatively healthy, although down from the second quarter of 2023 and not as strong as its crosstown rival General Motors, which released earnings Tuesday.

Here is what Wall Street is expecting, according to average estimates compiled by LSEG:

  • Earnings per share: 68 cents adjusted
  • Automotive revenue: $44.02 billion

Those results would mark a 3.8% increase in revenue compared to a year earlier and a 5.2% decline in adjusted earnings per share. Ford’s second-quarter results last year included $42.43 billion in revenue; net income of $1.92 billion, or 47 cents per share; and adjusted earnings before interest and taxes, or EBIT, of $3.79 billion.

Ford’s guidance for the year includes adjusted EBIT of between $10 billion and $12 billion and free cash flow of $6.5 billion to $7.5 billion.

Ford’s stock is up about 15% this year, as pricing in the automotive industry has remained more resilient than expected.

But as the industrywide transition to electric vehicles takes off more slowly than anticipated, the automaker has adjusted its product plans to focus less on all-electric vehicles and more on hybrids.

Most recently, Ford last week said it plans to expand production of its large Super Duty trucks to a Canadian plant that was previously set to be converted into an all-electric vehicle hub.

This is breaking news. Please check back for updates.

Don’t miss these insights from CNBC PRO



Source

Moderna says FDA refuses to review its application for experimental flu shot
Business

Moderna says FDA refuses to review its application for experimental flu shot

A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration has refused to start a review of Moderna‘s application for its experimental flu shot, the company announced Tuesday, in another sign of the […]

Read More
Estee Lauder sues Walmart alleging ‘despicable’ sale of counterfeit beauty products
Business

Estee Lauder sues Walmart alleging ‘despicable’ sale of counterfeit beauty products

Walmart Inc. signage during the company’s listing at the Nasdaq MarketSite in New York, US, on Tuesday, Dec. 9, 2025. Michael Nagle | Bloomberg | Getty Images Estee Lauder sued Walmart in California federal court over allegations the big-box retailer sold counterfeit beauty products on its website and didn’t do enough to ensure only authorized […]

Read More
How this French building behemoth wants to solve the U.S. housing dilemma
Business

How this French building behemoth wants to solve the U.S. housing dilemma

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox. French […]

Read More